Esperion Therapeutics, Inc.
ESPR · NASDAQ
Bulios Fair Price
$4.56
43.4% upside
Trenutna cena
$3.18
Po podatkih Bulios Fair Price je delnica ESPR trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Esperion Therapeutics, Inc. is an American biopharmaceutical company based in Ann Arbor, Michigan, focused on developing and commercializing innovative therapies to lower cholesterol and prevent cardiovascular disease. The company primarily targets patients who are unable to achieve their cholesterol goals with commonly available statins, offering alternative treatment options aimed at improving quality of life and reducing the risk of cardiac events.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Sheldon L. Koenig
Employees
294
Headquarters
Ann Arbor